We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-17.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10B
AUM Growth
-$4.54B
Cap. Flow
-$1.63B
Cap. Flow %
-16.3%
Top 10 Hldgs %
18.24%
Holding
2,308
New
654
Increased
395
Reduced
491
Closed
723

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$173M
2
EBAY icon
eBay
EBAY
+$149M
3
ZTS icon
Zoetis
ZTS
+$127M
4
TFX icon
Teleflex
TFX
+$108M
5
TMO icon
Thermo Fisher Scientific
TMO
+$98.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.96%
2 Consumer Discretionary 18.46%
3 Technology 13.47%
4 Financials 11.57%
5 Industrials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PARR icon
651
Par Pacific Holdings
PARR
$3.95B
$1.86M 0.02%
+261,296
New +$4.37M
SCHW
652
Charles Schwab
SCHW
$184B
$1.85M 0.02%
55,063
-99,284
-64% -$4.17M
CRBP icon
653
Corbus Pharmaceuticals
CRBP
$168M
$1.84M 0.02%
+11,706
New +$1.98M
ESTA icon
654
Establishment Labs
ESTA
$2.78B
$1.83M 0.02%
+126,419
New +$2.79M
SAH icon
655
Sonic Automotive
SAH
$3.3B
$1.83M 0.02%
+137,522
New +$3.59M
HP icon
656
Helmerich & Payne
HP
$3.26B
$1.82M 0.02%
116,338
-222,641
-66% -$7.84M
PSO icon
657
Pearson
PSO
$10.4B
$1.81M 0.02%
+262,119
New +$1.91M
PLUS icon
658
ePlus
PLUS
$2.42B
$1.79M 0.02%
57,282
+52,296
+1,049% +$1.99M
RVLV icon
659
Revolve Group
RVLV
$1.88B
$1.79M 0.02%
207,496
+151,764
+272% +$2.41M
JHG
660
DELISTED
Janus Henderson
JHG
$1.79M 0.02%
+116,944
New +$2.57M
BNFT
661
DELISTED
Benefitfocus, Inc.
BNFT
$1.78M 0.02%
200,258
+114,000
+132% +$1.73M
VYGR icon
662
Voyager Therapeutics
VYGR
$181M
$1.78M 0.02%
+194,444
New +$2.23M
VTR icon
663
Ventas
VTR
$47.8B
$1.77M 0.02%
+66,071
New +$3.28M
SYNH
664
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.77M 0.02%
44,969
-117,251
-72% -$6.86M
GOOD
665
Gladstone Commercial Corp
GOOD
$629M
$1.76M 0.02%
+122,955
New +$2.34M
SRDX
666
DELISTED
Surmodics
SRDX
$1.76M 0.02%
52,910
-24,909
-32% -$899K
ITB icon
667
iShares US Home Construction ETF
ITB
$2.43B
$1.76M 0.02%
+60,860
New +$2.61M
RGLD icon
668
Royal Gold
RGLD
$16.9B
$1.76M 0.02%
+20,066
New +$2.07M
SKY icon
669
Champion Homes
SKY
$4.62B
$1.75M 0.02%
111,696
-83,002
-43% -$2.22M
VRRM icon
670
Verra Mobility
VRRM
$650M
$1.75M 0.02%
245,210
-271,174
-53% -$3.61M
MCS icon
671
Marcus Corp
MCS
$766M
$1.75M 0.02%
142,039
+132,172
+1,340% +$3.33M
MATV icon
672
Mativ Holdings
MATV
$480M
$1.75M 0.02%
62,752
+31,833
+103% +$1.07M
HCKT icon
673
Hackett Group
HCKT
$271M
$1.74M 0.02%
136,948
+20,947
+18% +$314K
ACCO icon
674
Acco Brands
ACCO
$399M
$1.74M 0.02%
+344,538
New +$2.73M
ATR icon
675
AptarGroup
ATR
$8.77B
$1.74M 0.02%
17,478
-4,982
-22% -$540K

Similar funds

Marshall Wace's Q1 2020 Portfolio in Review

As of Q1 2020, Marshall Wace held 2,308 positions worth $10B, down 31% from $14.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace withdrew a net $1.63B in Q1 2020, closing 723 positions and reducing 491 holdings. Its most notable exit was eBay, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Marshall Wace opened a new position in Bank of Montreal worth $53.5M.

  • Marshall Wace's largest Q1 2020 buy was Bank of Montreal: 1,072,183 shares worth $53.5M.
  • Marshall Wace added most to Fidelity National Information Services in Q1 2020, an estimated $146M increase.
  • Marshall Wace's biggest Q1 2020 reduction was Boston Scientific, cutting an estimated $173M.
  • Marshall Wace fully exited eBay in Q1 2020, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 18% of its $10B portfolio in Q1 2020.
  • Marshall Wace opened 654 new positions and closed 723 in Q1 2020.
  • Marshall Wace's portfolio value fell 31% quarter-over-quarter to $10B.

Based on Marshall Wace's 13F filing for Q1 2020, filed 15 May 2020.